SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted drug beat standard care for hard-to-treat psychosis?
Disease control Recruiting nowThis study compares clozapine to risperidone in 320 adults with schizophrenia, schizoaffective disorder, or bipolar I with psychosis. Participants are grouped by a biological subtype (Biotype-1 or Biotype-2) to see if clozapine works better for certain brain types. The main goal …
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Apr 29, 2026 07:44 UTC
-
Magnetic seizures could replace ECT for schizophrenia
Disease control Recruiting nowThis study tests if magnetic seizure therapy (MST) can safely improve symptoms and thinking in people with schizophrenia that hasn't responded to standard medications. About 80 adults with treatment-resistant schizophrenia or schizoaffective disorder will receive MST, which uses …
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Apr 29, 2026 07:43 UTC
-
Can extra support keep people with early psychosis in treatment?
Knowledge-focused Recruiting nowThis study looks at whether adding five extra services—like peer support, digital outreach, and family therapy—to standard coordinated specialty care helps people with early psychosis stay in treatment longer. About 350 people starting care at six clinics will be assigned to eith…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Apr 29, 2026 07:41 UTC